Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody Engineering & Therapeutics Conference

EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & Therapeutics (AE&T) meeting, being held from December 4 – 8, 2022, in San Diego, California….

Click here to view original post